Alnylam Pharma (ALNY) Tops Q3 EPS by 8c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- Nasdaq ends higher as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) | Delayed: 160.34 +2.34 (1.48%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $158.00 | 52 Week High | $109.10 | |||
| Open | $158.94 | 52 Week Low | $31.38 | |||
| Day High | $161.58 | P/E | N/A | |||
| Day Low | $156.72 | EPS | $-1.45 | |||
| Volume | 2,709,177 | |||||
